BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 18, 2019
View Archived Issues
Microglia and AD
Read More
BRCA's effects range from indispensable to indifferent
Read More
Mimicking bone marrow keeps cultured blood stem cells quiescent
Read More
Polyphor closes phase III PRISM studies of murepavadin intravenous formulation
Read More
Positive topline data presented from phase IIb study of the TLPLDC vaccine
Read More
Recruitment ongoing in phase I/II study of FT-4101 in overweight/obese subjects with NASH
Read More
Tipepidine shows promise as a supplementary medication in children with ADHD
Read More
PledPharma reports results from POP phase I trial of calmangafodipir for paracetamol overdose
Read More
Results of exploratory analysis based on tumor location from phase II REACHIN study of regorafenib
Read More
Anti-SEMA4D antibody VX-15 may offer therapeutic potential for Alzheimer's disease
Read More
Intracutaneous zolmitriptan given high Migraine-ACT scores in clinical trial
Read More
Researchers test intranasal dantrolene for the treatment of Alzheimer's disease
Read More
X4 Pharmaceuticals patents CXCR4 antagonists
Read More
Bellus Health initiates phase II trial of BLU-5937 for unexplained or refractory chronic cough
Read More
Sterngreene presents new EGFR and HER2 inhibitors
Read More
Cyclerion Therapeutics synthesizes sGC activators
Read More
Presentation of data for PLX-R18 as prophylactic countermeasure for ARS
Read More
WHO declares Ebola outbreak in DRC a public health emergency of international concern
Read More
ChemoCentryx describes C5aR antagonists
Read More
Ribon Therapeutics discovers PARP14 inhibitors
Read More
Seelos submits IND for phase IIb/III study of SLS-005 for Sanfilippo syndrome
Read More
Cognitive and motor function enhanced by ASKT-4290 in aged mice
Read More
Apellis to develop APL-9 to target host responses to AAV vector administration
Read More